-
D646872-5mgDeruxtecan is an ADC drug-linker conjugate composed of an DX-8951 derivative (DXd) and amaleimide-GGFG peptide linker, used for synthesizing DS-8201 and U3-1402.In VitroAntibody-drug conjugates deliver anticancer agents selectively and efficiently
-
D650982-10mgDeruxtecan analog 2 (example 9 P3) is a Deruxtecan ( HY-13631E ) analog. Deruxtecan analog 2 is a agent-linker conjugate composed of Camptothecin ( HY-16560 ) and a linker. Camptothecin (CPT) is a Topo I inhibitor with antineoplastic activity
-
D650982-5mgDeruxtecan analog 2 (example 9 P3) is a Deruxtecan ( HY-13631E ) analog. Deruxtecan analog 2 is a agent-linker conjugate composed of Camptothecin ( HY-16560 ) and a linker. Camptothecin (CPT) is a Topo I inhibitor with antineoplastic activity
-
D340480-100mgDesthiobiotin-PEG3-azide is an azide PEG-linker.
-
D340480-25mgDesthiobiotin-PEG3-azide is an azide PEG-linker.
-
D340480-5mgDesthiobiotin-PEG3-azide is an azide PEG-linker.
-
D304080-1gDi(N-succinimidyl) adipate.
-
D304080-250mgDi(N-succinimidyl) adipate.
-
D304080-5gDi(N-succinimidyl) adipate.
-
D163549-100mgEthoxy or methoxyl silane functionalized polyethylene glycol, silane PEG (PEG-Si) is a surface reactive PEG derivative that can be used to modify glass, silica and other surfaces via the reaction between hydroxyl group and ethoxyl/methoxyl silane.
-
D163550-100mgEthoxy or methoxyl silane functionalized polyethylene glycol, silane PEG (PEG-Si) is a surface reactive PEG derivative that can be used to modify glass, silica and other surfaces via the reaction between hydroxyl group and ethoxyl/methoxyl silane.
-
D163550-500mgEthoxy or methoxyl silane functionalized polyethylene glycol, silane PEG (PEG-Si) is a surface reactive PEG derivative that can be used to modify glass, silica and other surfaces via the reaction between hydroxyl group and ethoxyl/methoxyl silane.